| Haley Conrad, | |
|
136 Simsbury Rd Bldg 16, Avon, CT 06001-3760 | |
| (860) 608-7366 | |
| Not Available |
| Full Name | Haley Conrad |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 136 Simsbury Rd Bldg 16, Avon, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265122519 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 14441629 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Haley Conrad, 45 Westwood Dr, Simsbury, CT 06070-1719 Ph: (860) 608-7366 | Haley Conrad, 136 Simsbury Rd Bldg 16, Avon, CT 06001-3760 Ph: (860) 608-7366 |
News Archive
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are testing a novel cellular immunotherapy approach to treating patients with diffuse large B-cell lymphoma who have failed standard therapy.
Cardiac arrest strikes almost 600,000 people each year, killing the vast majority of those individuals, says a new report from the Institute of Medicine. Every year in the U.S., approximately 395,000 cases of cardiac arrest occur outside of a hospital setting, in which less than 6 percent survive. Approximately 200,000 cardiac arrests occur each year in hospitals, and 24 percent of those patients survive. Estimates suggest that cardiac arrest is the third leading cause of death in the U.S. behind cancer and heart disease.
Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus.
Onyx Pharmaceuticals, Inc. today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. The company has an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) and received Scientific Advice from the European Medicines Agency (EMA) on the design and planned analysis of the ASPIRE trial.
China Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced unaudited financial results for the third quarter and first nine months ended December 31, 2009.
› Verified 2 days ago
Cynthia Romano, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Avon Meadow Ln, Avon, CT 06001 Phone: 860-284-9779 | |
Jennifer Lynn Lano, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35 Mountain View Ave, Avon, CT 06001 Phone: 203-910-6519 | |
Mrs. Judith Faith Rosenfield, M.A, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 56 East Main Street, Suite 202, Avon, CT 06001 Phone: 860-217-0098 Fax: 860-217-0742 | |
Annemarie Jordan, MS CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 87 Old Farms Rd, Avon, CT 06001 Phone: 860-673-0636 | |
Nicolette Kathleen Kovacs, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Avon Meadow Ln, Avon, CT 06001 Phone: 860-608-7366 | |
Mrs. Aimee Renee St Thomas, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 September Way, Avon, CT 06001 Phone: 203-581-4328 | |
Sarah Elizabeth White, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35 Mountain View Ave, Avon, CT 06001 Phone: 860-608-7366 |